ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163027; 2) Community: the network communities that were significantly associated with the response to NSC 163027; 3) Molecule: the relationships between components within communities and NSC 163027; 4) MDR: the compounds that were significantly associated with the NSC 163027.

NSC Compound Enrichment Correlation
NSC 380721 Eremantholide B 0.0273093708703111 0.55573582
NSC 38643 Lenamycin 0.0273093708703111 0.62780326
NSC 39135 Null 0.0273093708703111 0.4292834
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0273093708703111 0.78775401
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0273093708703111 0.36858012
NSC 621335 Null 0.0273093708703111 0.21236272
NSC 621336 Null 0.0273093708703111 0.56280061
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0273093708703111 0.54659324
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0273093708703111 0.29043434
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.0273093708703111 0.74948738
Total:88  Current:55    [First] [Prev] [Next] [Last]